Is it time to rethink the prevention and treatment of heart and circulatory diseases? Almost certainly. One common assertion regarding cardiovascular diseases is that there have been improvements as a result of cholesterol lowering drugs, primarily statins. Oddly, almost none of the trials investigating statins for primary prevention of heart disease have proven successful. Reduced rates of smoking have helped, whereas the widespread use of statins has not. Indeed, the trials...
Dallas Clouatre, PhD
Dallas Clouatre, Ph.D. earned his A.B. from Stanford and his Ph.D. from the University of California at Berkeley. A Fellow of the American College of Nutrition, he is a prominent industry consultant in the US, Europe, and Asia, and is a sought-after speaker and spokesperson. He is the author of numerous books. Recent publications include "Tocotrienols in Vitamin E: Hype or Science?" and "Vitamin E – Natural vs. Synthetic" in Tocotrienols: Vitamin E Beyond Tocopherols (2008), "Grape Seed Extract" in the Encyclopedia Of Dietary Supplements (2005), "Kava Kava: Examining New Reports of Toxicity" in Toxicology Letters (2004) and Anti-Fat Nutrients (4th edition).